|
Navarro-Núñez L, Castillo J, Lozano ML, Martínez C, Benavente-García O, Vicente V, Rivera J. Thromboxane A2 receptor antagonism by flavonoids: structure-activity relationships. J Agric Food Chem. 2009 Feb 25;57(4):1589-94. doi: 10.1021/jf803041k. PubMed PMID: 19182941.
AÑO: 2009; IF: 2.469
|
19182941
|
Moreno MJ, Lozano ML, Ferrer F, Bellosillo B, Besses C, Vicente V, Martínez C. ABO blood group does not increase the risk of thrombosis in Philadelphia-negative myeloproliferative disorders. Blood Coagul Fibrinolysis. 2009 Jul;20(5):390-2. doi: 10.1097/MBC.0b013e32832a9d7b. PubMed PMID: 19542939.
AÑO: 2009; IF: 1.246
|
|
Navarro-Núñez L, Rivera J, Guerrero JA, Martínez C, Vicente V, Lozano ML. Differential effects of quercetin, apigenin and genistein on signalling pathways of protease-activated receptors PAR(1) and PAR(4) in platelets. Br J Pharmacol. 2009 Nov;158(6):1548-56. doi: 10.1111/j.1476-5381.2009.00440.x. Epub 2009 Oct 8. PubMed PMID: 19814731; PubMed Central PMCID: PMC2795221.
AÑO: 2009; IF: 5.204
|
|
Giralt M., Navas V., Hernández-Nieto L., Burgaleta C., Carbonell F., Ramírez G., Vicente V., Besses C. Retrospective analysis of the efficacy and tolerability of anagrelide in patients with essential thrombocytemia: Spanish registry of essential thrombocytemia. Medicina Clinica. 20 June 2009. 133:86-90. 10.1016/j.medcli.2009.03.024
AÑO: 2009; IF: 1.231
|
|
Antón AI, Teruel R, Corral J, Miñano A, Martínez-Martínez I, Ordóñez A, Vicente V, Sánchez-Vega B. Functional consequences of the prothrombotic SERPINC1 rs2227589 polymorphism on antithrombin levels. Haematologica. 2009 Apr;94(4):589-92. doi: 10.3324/haematol.2008.000604. Epub 2009 Feb 19. PubMed PMID: 19229049; PubMed Central PMCID: PMC2663624.
AÑO: 2009; IF: 6.416
|